nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Doxorubicin—thyroid cancer	0.246	0.367	CbGbCtD
Tenofovir—ABCC4—Sorafenib—thyroid cancer	0.195	0.291	CbGbCtD
Tenofovir—ABCC2—Sorafenib—thyroid cancer	0.116	0.173	CbGbCtD
Tenofovir—ABCC2—Doxorubicin—thyroid cancer	0.0704	0.105	CbGbCtD
Tenofovir—CYP1A2—Sorafenib—thyroid cancer	0.0433	0.0645	CbGbCtD
Tenofovir—NME1—neck—thyroid cancer	0.00887	0.101	CbGeAlD
Tenofovir—Amylase increased—Vandetanib—thyroid cancer	0.00726	0.0335	CcSEcCtD
Tenofovir—AK4—saliva-secreting gland—thyroid cancer	0.00667	0.0762	CbGeAlD
Tenofovir—NME1-NME2—head—thyroid cancer	0.00644	0.0736	CbGeAlD
Tenofovir—NME1—Bosutinib—Vandetanib—thyroid cancer	0.00597	0.586	CbGdCrCtD
Tenofovir—Serum creatinine increased—Vandetanib—thyroid cancer	0.00562	0.026	CcSEcCtD
Tenofovir—AK2—thyroid gland—thyroid cancer	0.0055	0.0628	CbGeAlD
Tenofovir—AK4—trachea—thyroid cancer	0.00514	0.0588	CbGeAlD
Tenofovir—Amylase increased—Sorafenib—thyroid cancer	0.0049	0.0226	CcSEcCtD
Tenofovir—Tubulointerstitial nephritis—Vandetanib—thyroid cancer	0.00452	0.0209	CcSEcCtD
Tenofovir—NME1-NME2—lymph node—thyroid cancer	0.00451	0.0515	CbGeAlD
Tenofovir—NME1—thyroid gland—thyroid cancer	0.00422	0.0482	CbGeAlD
Tenofovir—AK4—thyroid gland—thyroid cancer	0.00407	0.0465	CbGeAlD
Tenofovir—Hypophosphataemia—Sorafenib—thyroid cancer	0.00401	0.0185	CcSEcCtD
Tenofovir—NME2—thyroid gland—thyroid cancer	0.00398	0.0454	CbGeAlD
Tenofovir—Proteinuria—Vandetanib—thyroid cancer	0.00394	0.0182	CcSEcCtD
Tenofovir—Protein urine present—Vandetanib—thyroid cancer	0.00388	0.0179	CcSEcCtD
Tenofovir—NME1—head—thyroid cancer	0.00375	0.0428	CbGeAlD
Tenofovir—Creatinine increased—Vandetanib—thyroid cancer	0.00363	0.0168	CcSEcCtD
Tenofovir—AK4—head—thyroid cancer	0.00361	0.0412	CbGeAlD
Tenofovir—Lactic acidosis—Epirubicin—thyroid cancer	0.00353	0.0163	CcSEcCtD
Tenofovir—NME2—head—thyroid cancer	0.00353	0.0403	CbGeAlD
Tenofovir—AK2—lymph node—thyroid cancer	0.00342	0.039	CbGeAlD
Tenofovir—Lactic acidosis—Doxorubicin—thyroid cancer	0.00327	0.0151	CcSEcCtD
Tenofovir—ABCC10—saliva-secreting gland—thyroid cancer	0.00316	0.0361	CbGeAlD
Tenofovir—Tubulointerstitial nephritis—Sorafenib—thyroid cancer	0.00305	0.0141	CcSEcCtD
Tenofovir—Proteinuria—Sorafenib—thyroid cancer	0.00265	0.0123	CcSEcCtD
Tenofovir—Rhabdomyolysis—Sorafenib—thyroid cancer	0.00264	0.0122	CcSEcCtD
Tenofovir—NME1—lymph node—thyroid cancer	0.00262	0.03	CbGeAlD
Tenofovir—Protein urine present—Sorafenib—thyroid cancer	0.00262	0.0121	CcSEcCtD
Tenofovir—AK4—lymph node—thyroid cancer	0.00253	0.0289	CbGeAlD
Tenofovir—NME2—lymph node—thyroid cancer	0.00247	0.0282	CbGeAlD
Tenofovir—ABCC10—trachea—thyroid cancer	0.00244	0.0279	CbGeAlD
Tenofovir—Adenosine triphosphate—AKT1—thyroid cancer	0.00244	1	CrCbGaD
Tenofovir—Blood creatinine increased—Vandetanib—thyroid cancer	0.00235	0.0109	CcSEcCtD
Tenofovir—Hypokalaemia—Vandetanib—thyroid cancer	0.00228	0.0106	CcSEcCtD
Tenofovir—NME1—Afatinib—Vandetanib—thyroid cancer	0.00225	0.221	CbGdCrCtD
Tenofovir—Nasopharyngitis—Vandetanib—thyroid cancer	0.00224	0.0104	CcSEcCtD
Tenofovir—Pancreatitis—Vandetanib—thyroid cancer	0.00213	0.00982	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00202	0.00931	CcSEcCtD
Tenofovir—NME1—Gefitinib—Vandetanib—thyroid cancer	0.00197	0.193	CbGdCrCtD
Tenofovir—Weight decreased—Vandetanib—thyroid cancer	0.00196	0.00907	CcSEcCtD
Tenofovir—Hyperglycaemia—Vandetanib—thyroid cancer	0.00196	0.00904	CcSEcCtD
Tenofovir—Pneumonia—Vandetanib—thyroid cancer	0.00195	0.00899	CcSEcCtD
Tenofovir—Infestation NOS—Vandetanib—thyroid cancer	0.00193	0.00894	CcSEcCtD
Tenofovir—Infestation—Vandetanib—thyroid cancer	0.00193	0.00894	CcSEcCtD
Tenofovir—ABCC10—thyroid gland—thyroid cancer	0.00193	0.0221	CbGeAlD
Tenofovir—Depression—Vandetanib—thyroid cancer	0.00193	0.00891	CcSEcCtD
Tenofovir—Renal failure—Vandetanib—thyroid cancer	0.0019	0.00878	CcSEcCtD
Tenofovir—Haematuria—Vandetanib—thyroid cancer	0.00184	0.00852	CcSEcCtD
Tenofovir—Renal failure acute—Sorafenib—thyroid cancer	0.00183	0.00847	CcSEcCtD
Tenofovir—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00183	0.00845	CcSEcCtD
Tenofovir—Sinusitis—Vandetanib—thyroid cancer	0.00181	0.00838	CcSEcCtD
Tenofovir—Urinary tract disorder—Vandetanib—thyroid cancer	0.00171	0.00792	CcSEcCtD
Tenofovir—Urethral disorder—Vandetanib—thyroid cancer	0.0017	0.00786	CcSEcCtD
Tenofovir—ABCC4—thyroid gland—thyroid cancer	0.0016	0.0183	CbGeAlD
Tenofovir—Mediastinal disorder—Vandetanib—thyroid cancer	0.00156	0.00723	CcSEcCtD
Tenofovir—Hypokalaemia—Sorafenib—thyroid cancer	0.00154	0.00712	CcSEcCtD
Tenofovir—Mental disorder—Vandetanib—thyroid cancer	0.00152	0.00703	CcSEcCtD
Tenofovir—Nasopharyngitis—Sorafenib—thyroid cancer	0.00151	0.00699	CcSEcCtD
Tenofovir—Malnutrition—Vandetanib—thyroid cancer	0.00151	0.00698	CcSEcCtD
Tenofovir—Hypophosphataemia—Epirubicin—thyroid cancer	0.00148	0.00685	CcSEcCtD
Tenofovir—Pancreatitis—Sorafenib—thyroid cancer	0.00143	0.00663	CcSEcCtD
Tenofovir—ABCC4—head—thyroid cancer	0.00142	0.0162	CbGeAlD
Tenofovir—SLC22A8—head—thyroid cancer	0.00141	0.0161	CbGeAlD
Tenofovir—Serum creatinine increased—Epirubicin—thyroid cancer	0.0014	0.00647	CcSEcCtD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—RET—thyroid cancer	0.00139	0.114	CbGpPWpGaD
Tenofovir—Hypophosphataemia—Doxorubicin—thyroid cancer	0.00137	0.00634	CcSEcCtD
Tenofovir—Weight decreased—Sorafenib—thyroid cancer	0.00132	0.00612	CcSEcCtD
Tenofovir—Pneumonia—Sorafenib—thyroid cancer	0.00131	0.00606	CcSEcCtD
Tenofovir—Infestation NOS—Sorafenib—thyroid cancer	0.0013	0.00603	CcSEcCtD
Tenofovir—Infestation—Sorafenib—thyroid cancer	0.0013	0.00603	CcSEcCtD
Tenofovir—Serum creatinine increased—Doxorubicin—thyroid cancer	0.0013	0.00599	CcSEcCtD
Tenofovir—Chest pain—Vandetanib—thyroid cancer	0.00129	0.00594	CcSEcCtD
Tenofovir—Arthralgia—Vandetanib—thyroid cancer	0.00129	0.00594	CcSEcCtD
Tenofovir—Renal failure—Sorafenib—thyroid cancer	0.00128	0.00592	CcSEcCtD
Tenofovir—Anxiety—Vandetanib—thyroid cancer	0.00128	0.00592	CcSEcCtD
Tenofovir—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00128	0.00591	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00128	0.0059	CcSEcCtD
Tenofovir—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00123	0.0057	CcSEcCtD
Tenofovir—Hepatomegaly—Epirubicin—thyroid cancer	0.00122	0.00563	CcSEcCtD
Tenofovir—Nervous system disorder—Vandetanib—thyroid cancer	0.00121	0.00559	CcSEcCtD
Tenofovir—ABCC10—lymph node—thyroid cancer	0.0012	0.0137	CbGeAlD
Tenofovir—Skin disorder—Vandetanib—thyroid cancer	0.0012	0.00554	CcSEcCtD
Tenofovir—Urinary tract disorder—Sorafenib—thyroid cancer	0.00116	0.00534	CcSEcCtD
Tenofovir—Connective tissue disorder—Sorafenib—thyroid cancer	0.00115	0.00532	CcSEcCtD
Tenofovir—Urethral disorder—Sorafenib—thyroid cancer	0.00115	0.0053	CcSEcCtD
Tenofovir—Hepatomegaly—Doxorubicin—thyroid cancer	0.00113	0.00521	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00112	0.00519	CcSEcCtD
Tenofovir—Insomnia—Vandetanib—thyroid cancer	0.00112	0.00515	CcSEcCtD
Tenofovir—Dyspnoea—Vandetanib—thyroid cancer	0.0011	0.00508	CcSEcCtD
Tenofovir—CYP1A2—thyroid gland—thyroid cancer	0.00109	0.0124	CbGeAlD
Tenofovir—Dyspepsia—Vandetanib—thyroid cancer	0.00109	0.00502	CcSEcCtD
Tenofovir—Decreased appetite—Vandetanib—thyroid cancer	0.00107	0.00495	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00107	0.00492	CcSEcCtD
Tenofovir—Glycosuria—Epirubicin—thyroid cancer	0.00106	0.00492	CcSEcCtD
Tenofovir—Fatigue—Vandetanib—thyroid cancer	0.00106	0.00491	CcSEcCtD
Tenofovir—Immune system disorder—Sorafenib—thyroid cancer	0.00106	0.00489	CcSEcCtD
Tenofovir—Mediastinal disorder—Sorafenib—thyroid cancer	0.00106	0.00488	CcSEcCtD
Tenofovir—Pain—Vandetanib—thyroid cancer	0.00105	0.00487	CcSEcCtD
Tenofovir—Mental disorder—Sorafenib—thyroid cancer	0.00103	0.00474	CcSEcCtD
Tenofovir—Malnutrition—Sorafenib—thyroid cancer	0.00102	0.00471	CcSEcCtD
Tenofovir—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00101	0.00466	CcSEcCtD
Tenofovir—ABCC4—lymph node—thyroid cancer	0.000995	0.0114	CbGeAlD
Tenofovir—Glycosuria—Doxorubicin—thyroid cancer	0.000985	0.00455	CcSEcCtD
Tenofovir—Abdominal pain—Vandetanib—thyroid cancer	0.000975	0.0045	CcSEcCtD
Tenofovir—Body temperature increased—Vandetanib—thyroid cancer	0.000975	0.0045	CcSEcCtD
Tenofovir—ABCC2—lymph node—thyroid cancer	0.000963	0.011	CbGeAlD
Tenofovir—Angioedema—Sorafenib—thyroid cancer	0.000932	0.0043	CcSEcCtD
Tenofovir—Creatinine increased—Epirubicin—thyroid cancer	0.000906	0.00418	CcSEcCtD
Tenofovir—Bone pain—Epirubicin—thyroid cancer	0.0009	0.00416	CcSEcCtD
Tenofovir—NME1—Arf6 trafficking events—TSHR—thyroid cancer	0.00089	0.0726	CbGpPWpGaD
Tenofovir—Asthenia—Vandetanib—thyroid cancer	0.000885	0.00409	CcSEcCtD
Tenofovir—Pruritus—Vandetanib—thyroid cancer	0.000873	0.00403	CcSEcCtD
Tenofovir—Arthralgia—Sorafenib—thyroid cancer	0.000868	0.00401	CcSEcCtD
Tenofovir—Myalgia—Sorafenib—thyroid cancer	0.000868	0.00401	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000862	0.00398	CcSEcCtD
Tenofovir—Diarrhoea—Vandetanib—thyroid cancer	0.000844	0.0039	CcSEcCtD
Tenofovir—Creatinine increased—Doxorubicin—thyroid cancer	0.000838	0.00387	CcSEcCtD
Tenofovir—Bone pain—Doxorubicin—thyroid cancer	0.000833	0.00385	CcSEcCtD
Tenofovir—Nervous system disorder—Sorafenib—thyroid cancer	0.000816	0.00377	CcSEcCtD
Tenofovir—Dizziness—Vandetanib—thyroid cancer	0.000816	0.00377	CcSEcCtD
Tenofovir—Skin disorder—Sorafenib—thyroid cancer	0.000808	0.00373	CcSEcCtD
Tenofovir—Anorexia—Sorafenib—thyroid cancer	0.000793	0.00366	CcSEcCtD
Tenofovir—Vomiting—Vandetanib—thyroid cancer	0.000784	0.00362	CcSEcCtD
Tenofovir—Rash—Vandetanib—thyroid cancer	0.000778	0.00359	CcSEcCtD
Tenofovir—Dermatitis—Vandetanib—thyroid cancer	0.000777	0.00359	CcSEcCtD
Tenofovir—Headache—Vandetanib—thyroid cancer	0.000773	0.00357	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000758	0.0035	CcSEcCtD
Tenofovir—Dyspnoea—Sorafenib—thyroid cancer	0.000742	0.00343	CcSEcCtD
Tenofovir—Nausea—Vandetanib—thyroid cancer	0.000733	0.00338	CcSEcCtD
Tenofovir—Dyspepsia—Sorafenib—thyroid cancer	0.000733	0.00338	CcSEcCtD
Tenofovir—Decreased appetite—Sorafenib—thyroid cancer	0.000723	0.00334	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000718	0.00332	CcSEcCtD
Tenofovir—Fatigue—Sorafenib—thyroid cancer	0.000717	0.00331	CcSEcCtD
Tenofovir—Pain—Sorafenib—thyroid cancer	0.000712	0.00329	CcSEcCtD
Tenofovir—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00068	0.00314	CcSEcCtD
Tenofovir—Renal failure acute—Epirubicin—thyroid cancer	0.000678	0.00313	CcSEcCtD
Tenofovir—Abdominal pain—Sorafenib—thyroid cancer	0.000658	0.00304	CcSEcCtD
Tenofovir—Body temperature increased—Sorafenib—thyroid cancer	0.000658	0.00304	CcSEcCtD
Tenofovir—Renal impairment—Epirubicin—thyroid cancer	0.000657	0.00304	CcSEcCtD
Tenofovir—Renal failure acute—Doxorubicin—thyroid cancer	0.000627	0.0029	CcSEcCtD
Tenofovir—Hypersensitivity—Sorafenib—thyroid cancer	0.000613	0.00283	CcSEcCtD
Tenofovir—Renal impairment—Doxorubicin—thyroid cancer	0.000608	0.00281	CcSEcCtD
Tenofovir—Asthenia—Sorafenib—thyroid cancer	0.000597	0.00276	CcSEcCtD
Tenofovir—Pruritus—Sorafenib—thyroid cancer	0.000589	0.00272	CcSEcCtD
Tenofovir—Blood creatinine increased—Epirubicin—thyroid cancer	0.000586	0.00271	CcSEcCtD
Tenofovir—Hypokalaemia—Epirubicin—thyroid cancer	0.000569	0.00263	CcSEcCtD
Tenofovir—Diarrhoea—Sorafenib—thyroid cancer	0.000569	0.00263	CcSEcCtD
Tenofovir—Nasopharyngitis—Epirubicin—thyroid cancer	0.00056	0.00258	CcSEcCtD
Tenofovir—Muscular weakness—Epirubicin—thyroid cancer	0.000552	0.00255	CcSEcCtD
Tenofovir—Dizziness—Sorafenib—thyroid cancer	0.00055	0.00254	CcSEcCtD
Tenofovir—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000542	0.00251	CcSEcCtD
Tenofovir—Pancreatitis—Epirubicin—thyroid cancer	0.00053	0.00245	CcSEcCtD
Tenofovir—Vomiting—Sorafenib—thyroid cancer	0.000529	0.00244	CcSEcCtD
Tenofovir—Hypokalaemia—Doxorubicin—thyroid cancer	0.000527	0.00243	CcSEcCtD
Tenofovir—Rash—Sorafenib—thyroid cancer	0.000525	0.00242	CcSEcCtD
Tenofovir—Dermatitis—Sorafenib—thyroid cancer	0.000524	0.00242	CcSEcCtD
Tenofovir—Headache—Sorafenib—thyroid cancer	0.000521	0.00241	CcSEcCtD
Tenofovir—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000518	0.00239	CcSEcCtD
Tenofovir—Muscular weakness—Doxorubicin—thyroid cancer	0.000511	0.00236	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000503	0.00232	CcSEcCtD
Tenofovir—Nausea—Sorafenib—thyroid cancer	0.000494	0.00228	CcSEcCtD
Tenofovir—Pancreatitis—Doxorubicin—thyroid cancer	0.000491	0.00227	CcSEcCtD
Tenofovir—Weight decreased—Epirubicin—thyroid cancer	0.000489	0.00226	CcSEcCtD
Tenofovir—Hyperglycaemia—Epirubicin—thyroid cancer	0.000488	0.00225	CcSEcCtD
Tenofovir—Pneumonia—Epirubicin—thyroid cancer	0.000485	0.00224	CcSEcCtD
Tenofovir—Infestation—Epirubicin—thyroid cancer	0.000482	0.00223	CcSEcCtD
Tenofovir—Infestation NOS—Epirubicin—thyroid cancer	0.000482	0.00223	CcSEcCtD
Tenofovir—Renal failure—Epirubicin—thyroid cancer	0.000474	0.00219	CcSEcCtD
Tenofovir—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000473	0.00218	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000465	0.00215	CcSEcCtD
Tenofovir—Sweating—Epirubicin—thyroid cancer	0.000462	0.00214	CcSEcCtD
Tenofovir—Haematuria—Epirubicin—thyroid cancer	0.00046	0.00212	CcSEcCtD
Tenofovir—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000456	0.00211	CcSEcCtD
Tenofovir—Weight decreased—Doxorubicin—thyroid cancer	0.000453	0.00209	CcSEcCtD
Tenofovir—Sinusitis—Epirubicin—thyroid cancer	0.000452	0.00209	CcSEcCtD
Tenofovir—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000451	0.00209	CcSEcCtD
Tenofovir—Pneumonia—Doxorubicin—thyroid cancer	0.000449	0.00207	CcSEcCtD
Tenofovir—Infestation NOS—Doxorubicin—thyroid cancer	0.000446	0.00206	CcSEcCtD
Tenofovir—Infestation—Doxorubicin—thyroid cancer	0.000446	0.00206	CcSEcCtD
Tenofovir—Renal failure—Doxorubicin—thyroid cancer	0.000439	0.00203	CcSEcCtD
Tenofovir—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000437	0.00202	CcSEcCtD
Tenofovir—Hepatitis—Epirubicin—thyroid cancer	0.000433	0.002	CcSEcCtD
Tenofovir—Sweating—Doxorubicin—thyroid cancer	0.000428	0.00198	CcSEcCtD
Tenofovir—Urinary tract disorder—Epirubicin—thyroid cancer	0.000427	0.00197	CcSEcCtD
Tenofovir—Haematuria—Doxorubicin—thyroid cancer	0.000425	0.00197	CcSEcCtD
Tenofovir—Connective tissue disorder—Epirubicin—thyroid cancer	0.000425	0.00197	CcSEcCtD
Tenofovir—Urethral disorder—Epirubicin—thyroid cancer	0.000424	0.00196	CcSEcCtD
Tenofovir—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000422	0.00195	CcSEcCtD
Tenofovir—Sinusitis—Doxorubicin—thyroid cancer	0.000419	0.00193	CcSEcCtD
Tenofovir—Hepatitis—Doxorubicin—thyroid cancer	0.000401	0.00185	CcSEcCtD
Tenofovir—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000396	0.00183	CcSEcCtD
Tenofovir—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000394	0.00182	CcSEcCtD
Tenofovir—Urethral disorder—Doxorubicin—thyroid cancer	0.000393	0.00181	CcSEcCtD
Tenofovir—Immune system disorder—Epirubicin—thyroid cancer	0.000391	0.00181	CcSEcCtD
Tenofovir—Mediastinal disorder—Epirubicin—thyroid cancer	0.00039	0.0018	CcSEcCtD
Tenofovir—Mental disorder—Epirubicin—thyroid cancer	0.000379	0.00175	CcSEcCtD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—TERT—thyroid cancer	0.000379	0.0309	CbGpPWpGaD
Tenofovir—Malnutrition—Epirubicin—thyroid cancer	0.000377	0.00174	CcSEcCtD
Tenofovir—Flatulence—Epirubicin—thyroid cancer	0.000371	0.00172	CcSEcCtD
Tenofovir—Back pain—Epirubicin—thyroid cancer	0.000365	0.00168	CcSEcCtD
Tenofovir—Immune system disorder—Doxorubicin—thyroid cancer	0.000362	0.00167	CcSEcCtD
Tenofovir—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000361	0.00167	CcSEcCtD
Tenofovir—Mental disorder—Doxorubicin—thyroid cancer	0.000351	0.00162	CcSEcCtD
Tenofovir—Malnutrition—Doxorubicin—thyroid cancer	0.000349	0.00161	CcSEcCtD
Tenofovir—Flatulence—Doxorubicin—thyroid cancer	0.000344	0.00159	CcSEcCtD
Tenofovir—Back pain—Doxorubicin—thyroid cancer	0.000337	0.00156	CcSEcCtD
Tenofovir—Myalgia—Epirubicin—thyroid cancer	0.000321	0.00148	CcSEcCtD
Tenofovir—Chest pain—Epirubicin—thyroid cancer	0.000321	0.00148	CcSEcCtD
Tenofovir—Arthralgia—Epirubicin—thyroid cancer	0.000321	0.00148	CcSEcCtD
Tenofovir—Anxiety—Epirubicin—thyroid cancer	0.00032	0.00148	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000319	0.00147	CcSEcCtD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—CCND1—thyroid cancer	0.000311	0.0254	CbGpPWpGaD
Tenofovir—ABCC4—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.00031	0.0252	CbGpPWpGaD
Tenofovir—Nervous system disorder—Epirubicin—thyroid cancer	0.000302	0.00139	CcSEcCtD
Tenofovir—Skin disorder—Epirubicin—thyroid cancer	0.000299	0.00138	CcSEcCtD
Tenofovir—Hyperhidrosis—Epirubicin—thyroid cancer	0.000297	0.00137	CcSEcCtD
Tenofovir—Chest pain—Doxorubicin—thyroid cancer	0.000297	0.00137	CcSEcCtD
Tenofovir—Arthralgia—Doxorubicin—thyroid cancer	0.000297	0.00137	CcSEcCtD
Tenofovir—Myalgia—Doxorubicin—thyroid cancer	0.000297	0.00137	CcSEcCtD
Tenofovir—Anxiety—Doxorubicin—thyroid cancer	0.000296	0.00137	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000295	0.00136	CcSEcCtD
Tenofovir—Anorexia—Epirubicin—thyroid cancer	0.000293	0.00135	CcSEcCtD
Tenofovir—ABCC4—Ectoderm Differentiation—TRIM33—thyroid cancer	0.000288	0.0235	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—TERT—thyroid cancer	0.000287	0.0234	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00028	0.00129	CcSEcCtD
Tenofovir—Nervous system disorder—Doxorubicin—thyroid cancer	0.000279	0.00129	CcSEcCtD
Tenofovir—Insomnia—Epirubicin—thyroid cancer	0.000278	0.00128	CcSEcCtD
Tenofovir—AK2—Metabolism—MINPP1—thyroid cancer	0.000277	0.0226	CbGpPWpGaD
Tenofovir—Skin disorder—Doxorubicin—thyroid cancer	0.000276	0.00128	CcSEcCtD
Tenofovir—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000275	0.00127	CcSEcCtD
Tenofovir—Dyspnoea—Epirubicin—thyroid cancer	0.000274	0.00127	CcSEcCtD
Tenofovir—Anorexia—Doxorubicin—thyroid cancer	0.000271	0.00125	CcSEcCtD
Tenofovir—Dyspepsia—Epirubicin—thyroid cancer	0.000271	0.00125	CcSEcCtD
Tenofovir—Decreased appetite—Epirubicin—thyroid cancer	0.000267	0.00123	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000266	0.00123	CcSEcCtD
Tenofovir—Fatigue—Epirubicin—thyroid cancer	0.000265	0.00122	CcSEcCtD
Tenofovir—Pain—Epirubicin—thyroid cancer	0.000263	0.00121	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000259	0.0012	CcSEcCtD
Tenofovir—Insomnia—Doxorubicin—thyroid cancer	0.000257	0.00119	CcSEcCtD
Tenofovir—Dyspnoea—Doxorubicin—thyroid cancer	0.000254	0.00117	CcSEcCtD
Tenofovir—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000251	0.00116	CcSEcCtD
Tenofovir—Dyspepsia—Doxorubicin—thyroid cancer	0.00025	0.00116	CcSEcCtD
Tenofovir—Decreased appetite—Doxorubicin—thyroid cancer	0.000247	0.00114	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000246	0.00113	CcSEcCtD
Tenofovir—Fatigue—Doxorubicin—thyroid cancer	0.000245	0.00113	CcSEcCtD
Tenofovir—Pain—Doxorubicin—thyroid cancer	0.000243	0.00112	CcSEcCtD
Tenofovir—Abdominal pain—Epirubicin—thyroid cancer	0.000243	0.00112	CcSEcCtD
Tenofovir—Body temperature increased—Epirubicin—thyroid cancer	0.000243	0.00112	CcSEcCtD
Tenofovir—ABCC2—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00024	0.0196	CbGpPWpGaD
Tenofovir—AK2—Metabolism—NDUFA13—thyroid cancer	0.000236	0.0192	CbGpPWpGaD
Tenofovir—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000233	0.00107	CcSEcCtD
Tenofovir—Hypersensitivity—Epirubicin—thyroid cancer	0.000227	0.00105	CcSEcCtD
Tenofovir—Body temperature increased—Doxorubicin—thyroid cancer	0.000225	0.00104	CcSEcCtD
Tenofovir—Abdominal pain—Doxorubicin—thyroid cancer	0.000225	0.00104	CcSEcCtD
Tenofovir—AK2—Metabolism—CHST14—thyroid cancer	0.000222	0.0181	CbGpPWpGaD
Tenofovir—Asthenia—Epirubicin—thyroid cancer	0.000221	0.00102	CcSEcCtD
Tenofovir—Pruritus—Epirubicin—thyroid cancer	0.000218	0.00101	CcSEcCtD
Tenofovir—Diarrhoea—Epirubicin—thyroid cancer	0.00021	0.000972	CcSEcCtD
Tenofovir—Hypersensitivity—Doxorubicin—thyroid cancer	0.00021	0.000968	CcSEcCtD
Tenofovir—Asthenia—Doxorubicin—thyroid cancer	0.000204	0.000943	CcSEcCtD
Tenofovir—Dizziness—Epirubicin—thyroid cancer	0.000203	0.000939	CcSEcCtD
Tenofovir—Pruritus—Doxorubicin—thyroid cancer	0.000201	0.00093	CcSEcCtD
Tenofovir—Vomiting—Epirubicin—thyroid cancer	0.000196	0.000903	CcSEcCtD
Tenofovir—Diarrhoea—Doxorubicin—thyroid cancer	0.000195	0.000899	CcSEcCtD
Tenofovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.000195	0.0159	CbGpPWpGaD
Tenofovir—Rash—Epirubicin—thyroid cancer	0.000194	0.000896	CcSEcCtD
Tenofovir—Dermatitis—Epirubicin—thyroid cancer	0.000194	0.000895	CcSEcCtD
Tenofovir—Headache—Epirubicin—thyroid cancer	0.000193	0.00089	CcSEcCtD
Tenofovir—ABCC4—Ectoderm Differentiation—TCF7L1—thyroid cancer	0.000192	0.0157	CbGpPWpGaD
Tenofovir—NME2—Metabolism—MINPP1—thyroid cancer	0.000192	0.0157	CbGpPWpGaD
Tenofovir—Dizziness—Doxorubicin—thyroid cancer	0.000188	0.000869	CcSEcCtD
Tenofovir—Nausea—Epirubicin—thyroid cancer	0.000183	0.000844	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000182	0.0149	CbGpPWpGaD
Tenofovir—Vomiting—Doxorubicin—thyroid cancer	0.000181	0.000836	CcSEcCtD
Tenofovir—Rash—Doxorubicin—thyroid cancer	0.000179	0.000829	CcSEcCtD
Tenofovir—Dermatitis—Doxorubicin—thyroid cancer	0.000179	0.000828	CcSEcCtD
Tenofovir—AK2—Metabolism—HPGD—thyroid cancer	0.000179	0.0146	CbGpPWpGaD
Tenofovir—Headache—Doxorubicin—thyroid cancer	0.000178	0.000823	CcSEcCtD
Tenofovir—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000175	0.0143	CbGpPWpGaD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—AKT1—thyroid cancer	0.000173	0.0141	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.000171	0.0139	CbGpPWpGaD
Tenofovir—Nausea—Doxorubicin—thyroid cancer	0.000169	0.000781	CcSEcCtD
Tenofovir—NME2—Metabolism—NDUFA13—thyroid cancer	0.000163	0.0133	CbGpPWpGaD
Tenofovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.000162	0.0132	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—thyroid cancer	0.000156	0.0127	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CHST14—thyroid cancer	0.000154	0.0125	CbGpPWpGaD
Tenofovir—NME1—Metabolism—MINPP1—thyroid cancer	0.000146	0.0119	CbGpPWpGaD
Tenofovir—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000145	0.0118	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—TP53—thyroid cancer	0.000144	0.0118	CbGpPWpGaD
Tenofovir—NME2—Metabolism—HPGD—thyroid cancer	0.000124	0.0101	CbGpPWpGaD
Tenofovir—NME1—Metabolism—NDUFA13—thyroid cancer	0.000124	0.0101	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000118	0.00965	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—CP—thyroid cancer	0.000118	0.00965	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CHST14—thyroid cancer	0.000116	0.0095	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000116	0.0095	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—TP53—thyroid cancer	0.000109	0.00891	CbGpPWpGaD
Tenofovir—AK2—Metabolism—TPR—thyroid cancer	0.000103	0.00837	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PRKAR1A—thyroid cancer	0.000101	0.00824	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—SLC5A5—thyroid cancer	0.000101	0.00821	CbGpPWpGaD
Tenofovir—NME1—Metabolism—HPGD—thyroid cancer	9.39e-05	0.00766	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	9.06e-05	0.00739	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.86e-05	0.00722	CbGpPWpGaD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—TPR—thyroid cancer	8.85e-05	0.00721	CbGpPWpGaD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—CP—thyroid cancer	8.85e-05	0.00721	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—SLC5A5—thyroid cancer	8.49e-05	0.00693	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—RXRA—thyroid cancer	8.46e-05	0.0069	CbGpPWpGaD
Tenofovir—ABCC4—Fluoropyrimidine Activity—TP53—thyroid cancer	8.22e-05	0.0067	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	8.18e-05	0.00667	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	7.96e-05	0.00649	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	7.9e-05	0.00644	CbGpPWpGaD
Tenofovir—AK2—Metabolism—SLC5A5—thyroid cancer	7.68e-05	0.00627	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.44e-05	0.00607	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—TPR—thyroid cancer	7.38e-05	0.00602	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—CP—thyroid cancer	7.38e-05	0.00602	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—NRG1—thyroid cancer	7.32e-05	0.00597	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—RXRA—thyroid cancer	7.14e-05	0.00582	CbGpPWpGaD
Tenofovir—NME2—Metabolism—TPR—thyroid cancer	7.12e-05	0.0058	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PRKAR1A—thyroid cancer	7e-05	0.00571	CbGpPWpGaD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	6.62e-05	0.0054	CbGpPWpGaD
Tenofovir—AK2—Metabolism—RXRA—thyroid cancer	6.46e-05	0.00527	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—NRG1—thyroid cancer	6.17e-05	0.00503	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	6.07e-05	0.00495	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	5.53e-05	0.00451	CbGpPWpGaD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	5.46e-05	0.00445	CbGpPWpGaD
Tenofovir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	5.43e-05	0.00443	CbGpPWpGaD
Tenofovir—NME1—Metabolism—TPR—thyroid cancer	5.39e-05	0.0044	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	5.39e-05	0.0044	CbGpPWpGaD
Tenofovir—NME2—Metabolism—SLC5A5—thyroid cancer	5.33e-05	0.00434	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PRKAR1A—thyroid cancer	5.3e-05	0.00433	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PRKAR1A—thyroid cancer	4.9e-05	0.00399	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	4.55e-05	0.00371	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—TPR—thyroid cancer	4.49e-05	0.00367	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—CP—thyroid cancer	4.49e-05	0.00367	CbGpPWpGaD
Tenofovir—NME2—Metabolism—RXRA—thyroid cancer	4.48e-05	0.00365	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	4.42e-05	0.00361	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.42e-05	0.00361	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—TPR—thyroid cancer	4.31e-05	0.00351	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—CP—thyroid cancer	4.31e-05	0.00351	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.24e-05	0.00346	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PPARG—thyroid cancer	4.08e-05	0.00332	CbGpPWpGaD
Tenofovir—NME1—Metabolism—SLC5A5—thyroid cancer	4.04e-05	0.00329	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—TPR—thyroid cancer	3.75e-05	0.00306	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	3.75e-05	0.00306	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.69e-05	0.00301	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—TPR—thyroid cancer	3.63e-05	0.00296	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—CP—thyroid cancer	3.63e-05	0.00296	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.57e-05	0.00292	CbGpPWpGaD
Tenofovir—NME1—Metabolism—RXRA—thyroid cancer	3.39e-05	0.00277	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.36e-05	0.00274	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	3.35e-05	0.00273	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IFNA2—thyroid cancer	3.24e-05	0.00265	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.23e-05	0.00263	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTGS2—thyroid cancer	3.21e-05	0.00262	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	3.14e-05	0.00256	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.83e-05	0.00231	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PPARG—thyroid cancer	2.83e-05	0.0023	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.81e-05	0.00229	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTEN—thyroid cancer	2.8e-05	0.00228	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.72e-05	0.00222	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.71e-05	0.00221	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	2.61e-05	0.00213	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	2.5e-05	0.00204	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.36e-05	0.00192	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—RXRA—thyroid cancer	2.35e-05	0.00192	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.29e-05	0.00186	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	2.24e-05	0.00183	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTGS2—thyroid cancer	2.22e-05	0.00181	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PPARG—thyroid cancer	2.14e-05	0.00175	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTEN—thyroid cancer	1.94e-05	0.00158	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	1.91e-05	0.00156	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MINPP1—thyroid cancer	1.73e-05	0.00141	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTGS2—thyroid cancer	1.68e-05	0.00137	CbGpPWpGaD
Tenofovir—AK2—Metabolism—AKT1—thyroid cancer	1.61e-05	0.00131	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.52e-05	0.00124	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTEN—thyroid cancer	1.47e-05	0.0012	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NDUFA13—thyroid cancer	1.47e-05	0.0012	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CHST14—thyroid cancer	1.38e-05	0.00113	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—NRAS—thyroid cancer	1.21e-05	0.000987	CbGpPWpGaD
Tenofovir—NME2—Metabolism—AKT1—thyroid cancer	1.12e-05	0.000911	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—HPGD—thyroid cancer	1.11e-05	0.000907	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—KRAS—thyroid cancer	1.04e-05	0.000849	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—thyroid cancer	9.26e-06	0.000755	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.02e-06	0.000736	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HRAS—thyroid cancer	8.85e-06	0.000722	CbGpPWpGaD
Tenofovir—NME1—Metabolism—AKT1—thyroid cancer	8.47e-06	0.00069	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—AKT1—thyroid cancer	7.82e-06	0.000637	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TPR—thyroid cancer	6.39e-06	0.000521	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	6.28e-06	0.000513	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.7e-06	0.000465	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC5A5—thyroid cancer	4.78e-06	0.00039	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.48e-06	0.000365	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—RXRA—thyroid cancer	4.02e-06	0.000328	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.91e-06	0.000319	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PPARG—thyroid cancer	2.54e-06	0.000207	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTGS2—thyroid cancer	2e-06	0.000163	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTEN—thyroid cancer	1.74e-06	0.000142	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AKT1—thyroid cancer	1e-06	8.18e-05	CbGpPWpGaD
